RECODE THERAPEUTICS, INC.

Profile

Company Names

RECODE THERAPEUTICS, INC.

Addresses

1140 O-BRIEN DRIVE, MENLO PARK, CA 94025

1140 O-BRIEN DR, MENLO PARK, CA 94025

1455 ADAMS DRIVE, STE 1120, MENLO PARK, CA 94025

1455 ADAMS DRIVE, SUITE 1120, MENLO PARK, CA 94025

1455 ADAMS DRIVE, MENLO PARK, CA 94025

815 NATIONAL DR., IRVING, TX 75060

Phone Numbers

408-585-1700
(408) 585-1700
408-585-1718
979-574-0894

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2015

State Incorporated:

TEXAS

Total Amount Raised:

$318,741,320.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-09-23 
$29,441,931.00 
$29,441,931.00 
$0.00 
Debt 
3
2021-10-13 
$259,799,396.00 
$290,000,113.00 
$30,200,717.00 
Equity 
2
2020-03-06 
$27,499,993.00 
$79,999,973.00 
$52,499,980.00 
Equity 
1
2016-12-16 
$2,000,000.00 
$3,000,000.00 
$1,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RANA 
 
AL-HALLAQ 
DIRECTOR
BLADE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  REFLEXION MEDICAL, INC.
ALAN 
 
COLOWICK 
DIRECTOR
NORA THERAPEUTICS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  VELOSBIO INC.   |  INCARDA THERAPEUTICS, INC.   |  SOLVE THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ANUMANA, INC.   |  HARPOON THERAPEUTICS, INC.   |  ALUMIS INC.
RAKHSHITA 
 
DHAR 
DIRECTOR
RECODE THERAPEUTICS, INC.   |  NEXTPOINT THERAPEUTICS, INC.   |  DEKA BIOSCIENCES, INC.   |  GRO BIOSCIENCES INC.   |  SONOTHERA, INC.
JULIA 
 
EASTLAND 
EXECUTIVE OFFICER
ONCOTHYREON INC.   |  RECODE THERAPEUTICS, INC.
KOUKI 
 
HARASAKI 
DIRECTOR
ARTIFICIAL, INC.   |  KARLSGATE INC.   |  SURGE THERAPEUTICS, INC.   |  ENSOMA, INC.   |  RECODE THERAPEUTICS, INC.   |  BIOLUMINESCENCE VENTURES FUND I, L.P.   |  BIOLUMINESCENCE VENTURES FUND II, L.P.
EDWARD 
 
HURWITZ 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  APPLIED GENETIC TECHNOLOGIES CORP   |  PROTEGO BIOPHARMA   |  RECODE THERAPEUTICS, INC.   |  DYNE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA, INC.
ARTHUR 
E 
JOHNSON 
EXECUTIVE OFFICER, DIRECTOR
RECODE THERAPEUTICS, INC.
HELEN 
 
KIM 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  NGM BIOPHARMACEUTICALS INC   |  NEOGENE THERAPEUTICS, INC.   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  RECODE THERAPEUTICS, INC.   |  PROTEGO BIOPHARMA   |  PROTEGO BIOPHARMA, INC.
HELEN 
S. 
KIM 
DIRECTOR
EXICURE, INC.   |  EXICURE, INC.   |  A2 BIOTHERAPEUTICS, INC.   |  ICONOVIR BIO, INC.   |  RECODE THERAPEUTICS, INC.   |  AKTIS ONCOLOGY, INC.
DAVID 
 
LOCKHART 
EXECUTIVE OFFICER
CHIMEROS INC   |  AMICUS THERAPEUTICS INC   |  RECODE THERAPEUTICS, INC.
DAVID 
J 
LOCKHART 
EXECUTIVE OFFICER, DIRECTOR
RECODE THERAPEUTICS, INC.
DAVID 
J. 
LOCKHART 
EXECUTIVE OFFICER, DIRECTOR
AMICUS THERAPEUTICS INC   |  RECODE THERAPEUTICS, INC.
PATRICIA 
 
MILLICAN 
DIRECTOR
METACRINE, INC.   |  RECODE THERAPEUTICS, INC.
TRISHA 
 
MILLICAN 
DIRECTOR
METACRINE, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  RECODE THERAPEUTICS, INC.
DEAN 
 
MITCHELL 
DIRECTOR
LUX BIOSCIENCES INC   |  KINNATE BIOPHARMA INC.   |  RECODE THERAPEUTICS, INC.
OLEG 
 
NODELMAN 
DIRECTOR
BIOTECHNOLOGY VALUE FUND II LP   |  BIOTECHNOLOGY VALUE FUND L P   |  ECOR1 CAPITAL FUND, L.P.   |  ECOR1 CAPITAL FUND QUALIFIED, L.P.   |  ECOR1 VENTURE OPPORTUNITY FUND, LP   |  ECOR1 VENTURE OPPORTUNITY OFFSHORE FUND, L.P.   |  RECODE THERAPEUTICS, INC.   |  SCORPION THERAPEUTICS, INC.   |  AKTIS ONCOLOGY, INC.   |  EPIKAST INC.
INAI 
 
PARK 
DIRECTOR
RECODE THERAPEUTICS, INC.
RA 
 
SESSION II 
DIRECTOR
RECODE THERAPEUTICS, INC.   |  TAYSHA GENE THERAPIES, INC.
SHEHNAAZ 
 
SULIMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RECODE THERAPEUTICS, INC.
PETER 
 
THOMPSON 
DIRECTOR
TRUBION PHARMACEUTICALS, INC   |  RESPONSE BIOMEDICAL CORP   |  TV ONE LLC   |  TV ONE CAPITAL CORP.   |  CODA THERAPEUTICS INC   |  METHYLGENE INC.   |  CARDIOXYL PHARMACEUTICALS INC   |  PRONAI THERAPEUTICS INC   |  EQDERIVATIVES, INC.   |  ADAPTIMMUNE LTD   |  CORVUS PHARMACEUTICALS, INC.   |  PRINCIPIA BIOPHARMA INC.   |  E-SCAPE BIO, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  CLEAVE BIOSCIENCES, INC.   |  PMV PHARMACEUTICALS, INC.   |  PREVAIL THERAPEUTICS INC.   |  SYNTHORX, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  EDGEWISE THERAPEUTICS, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ESCAPE BIO, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  ALPHEUS MEDICAL, INC.   |  GENNAO BIO, INC.   |  TERREMOTO BIOSCIENCES, INC.
PETER 
A. 
THOMPSON 
DIRECTOR
RESPONSE BIOMEDICAL CORP   |  SILVERBACK THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.   |  RECODE THERAPEUTICS, INC.   |  ORBIMED NEW HORIZONS FUND, L.P.   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED GENESIS FUND, L.P.   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES IV, LP   |  ORBIMED RCO IV OFFSHORE FEEDER, LP   |  ORBIMED PRIVATE INVESTMENTS IX, LP   |  ORBIMED RCO V OFFSHORE FEEDER, LP   |  ORBIMED ROYALTY + CREDIT OPPORTUNITIES V, LP
MICHAEL 
 
TORRES 
DIRECTOR
MARKETOCRACY, INC.   |  GREENWORLD HOMES USA + CARIBBEAN, INC.   |  COLOVORE LLC   |  RECODE THERAPEUTICS, INC.   |  RENOVA THERAPEUTICS, INC.   |  CROSSBRIDGE BIO, INC.   |  WEARLINQ, INC.   |  MEL-MONT MEDICAL, INC.
BASHEER 
 
ZADA 
DIRECTOR
RECODE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-10-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-09-23 
2023-09-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2023-01-27
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-10-13 
2022-07-06
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2021-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-13 
2020-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-06 
2019-02-08
D/A
Link
OTHER HEALTH CARE 
 
$1 - $1,000,000 
Equity 
2016-12-16 
2017-03-02
D/A
Link
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2016-12-16 
2017-01-05
D
Link
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2016-12-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#